MEDRAD has long been a leader in developing innovative medical device products* that improve the quality of healthcare and enable cost-effective patient care. Recent examples include:
The Certegra™ Informatics Platform that automates personalized injection protocol personalization; integrates patient/study information with clinical systems; automates record keeping; and provides flexible access to more complete, accurate data.
The Intego™ PET Infusion System that automates the administration of Fluorodeoxyglucose (FDG) for Positron Emission Tomography/Computed Tomography (PET/CT) procedures and reduces the technologist's exposure to radiation by a minimum 20 pecent.
The Continuum Wireless MR Infusion System that controls a patient’s medication infusion from inside and outside the scan room, enabling a clinician to control parameters without interrupting the MR scan.
Extravasation detector technology that directly senses extravasation pooling of contrast agent under the skin during a CT scanning procedure. (Medical Design Excellence Award® Winner 2008)
Personalized Patient Protocol Technology (P3T®) that makes it possible to further customize a CT injection based on patient-specific parameters.
A Magnetic Resonance (MR) endorectal coil that conforms to the size and shape of the prostate to provide clearer pictures needed to diagnose and stage cancer and plan targeted treatment.
The Avanta™ Fluid Management Injection System is designed to allow controlled flow automated injections to the coronaries. The combination of single patient and multi-patient disposables supports a single set-up for use with multiple patients.
AngioJet® Ultra Thrombectomy System is used to remove thrombus from blocked vessels. Pressurized saline is sent to the tip of a catheter to create a vacuum that draws in thrombus and removes it from the body.
With its unique 0.035" guidewire and CO2 filled occlusion balloon, the GuardDOG® Occlusion System can temporarily occlude blood flow and support over-the-wire interventional devices including catheter-directed lytic therapy.
* All MEDRAD products must be employed and used properly to achieve benefits. See respective Operator's Manuals for details.
Return to History section